skc
Goldmember
- Joined
- 12 August 2008
- Posts
- 8,277
- Reactions
- 329
New Position
10/2/2011 Buy 150,000 CAJ @ 3.7c = $5,550.
Rationale
CAJ is a small scale independent diagnostic imaging outfit with 28 sites. FY09/10 was a turnaround year when the company grew revenue by 25% and posted a small NPAT of $0.7m (vs $1.3m loss the year before).
In FY10/11 management is forecasting $1.6m NPAT supposed by 9 new sites and like-for-like growth (14% from FY09 to FY10). That however may be conservative given that Sept Qtr already saw NPAT ~$0.5m.
If they can achieve $2m profit (0.66cps) and 15% growth for a few more years, the current PE of ~6 is more than cheap compared to larger listed firms operating in similar fields (PRY PE=13, SHL PE=15.6).
Exit target with PE~10 or 6.5-7c.
P.S. CAJ reports tomorrow so I am sticking my neck out here a bit on expectation of a good result.
CAJ released the full report today. Everything pretty much as per forecasted. NPAT $732K and positive operating cash flow of $2.9m. Full year PBT guidance of $2.25 may be exceeded by 3-4% (that's the smallest upgrade ever...).
Balance sheet probably a little bit weak. They invested a fair bit in plants/equipment and leases so cash balance is unchanged from last period at ~$850K.
Continue to hold, but it didn't have the boost to share price that I was looking for.